{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:37:22Z","timestamp":1780072642770,"version":"3.54.0"},"reference-count":30,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interv Cardiol"],"abstract":"<jats:p>Aortic valve stenosis is the most common valvular lesion in Australia, with a rising prevalence in line with the ageing population. Recent trials have demonstrated the efficacy of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement in consecutively lower surgical risk patient cohorts. Despite this, the current indication for TAVI in Australia is for the treatment of severe symptomatic aortic stenosis in patients who are of prohibitive or high surgical risk and ultimately deemed suitable by a heart team. This article summarises the trends in TAVI in Australia over the last 5 years in terms of funding, accreditation and service delivery, as well as advances in technique, technology, patient selection and local outcomes.<\/jats:p>","DOI":"10.15420\/icr.2021.27","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T13:26:45Z","timestamp":1647869205000},"source":"Crossref","is-referenced-by-count":8,"title":["Trends in Transcatheter Aortic Valve Implantation in Australia"],"prefix":"10.15420","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-6933","authenticated-orcid":false,"given":"Rhys","family":"Gray","sequence":"first","affiliation":[{"name":"Department of Cardiology, Prince of Wales Hospital, Sydney, Australia; Prince of Wales Clinical School, University of New South Wales Medicine, Sydney, Australia; Eastern Heart Clinic, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5969-4962","authenticated-orcid":false,"given":"Kiran","family":"Sarathy","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Prince of Wales Hospital, Sydney, Australia; Prince of Wales Clinical School, University of New South Wales Medicine, Sydney, Australia; Eastern Heart Clinic, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Adams HSL, Ashokkumar S, Newcomb A, et al. Contemporary review of severe aortic stenosis. Intern Med J 2019;49:297\u2013305. https:\/\/doi.org\/10.1111\/imj.14071; PMID:\u00a030091235.","DOI":"10.1111\/imj.14071"},{"key":"ref1","unstructured":"Australian Bureau of Statistics. Population Projections, Australia, 2017\u20132066. 2018. https:\/\/www.abs.gov.au\/statistics\/people\/population\/population-projections-australia\/latest-release (accessed 11 January 2022)."},{"key":"ref2","unstructured":"Statistics New Zealand. National population projections, by age and sex, 2020(base)-2073. http:\/\/nzdotstat.stats.govt.nz\/wbos\/Index.aspx?DataSetCode=TABLECODE7542&_ga=2.37673888.1874216751.1603887453-113855905.1603887453# (accessed 20 January 2022)."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Durko AP, Osnabrugge RL, Van Mieghem NM,  et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J 2018;39:2635\u201342. https:\/\/doi.org\/10.1093\/eurheartj\/ehy107; PMID:\u00a029546396.","DOI":"10.1093\/eurheartj\/ehy107"},{"key":"ref4","unstructured":"Sverdlov AL, Ngo DT, Chapman MJ,  et al. Pathogenesis of aortic stenosis: not just a matter of wear and tear. Am J Cardiovasc Dis 2011;1:185\u201399; PMID:\u00a022254198"},{"key":"ref5","unstructured":"Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597\u2013607. https:\/\/doi.org\/10.1056\/NEJMoa1008232; PMID:\u00a020961243."},{"key":"ref6","unstructured":"Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1103510; PMID:\u00a021639811."},{"key":"ref7","unstructured":"Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1514616; PMID:\u00a027040324."},{"key":"ref8","unstructured":"Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1814052; PMID:\u00a030883058."},{"key":"ref9","unstructured":"Australian Government department of Health, MBS listing for transcatheter aortic valve implantation. http:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Factsheet-TAVI (accessed 20 January 2022)"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Nelson AJ, Montarello NJ, Cosgrove CS, et al. Transcatheter aortic valve implantation: a new standard of care. Med J Aust 2018;209:136\u201341. https:\/\/doi.org\/10.5694\/mja17.01255; PMID:\u00a030071816.","DOI":"10.5694\/mja17.01255"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Bennetts J, Sinhal A, Walters D, et al. 2021 CSANZ and ANZSCTS Position Statement on the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program in Australia. Heart Lung Circ 2021;30:1811\u20138. https:\/\/doi.org\/10.1016\/j.hlc.2021.07.017; PMID:\u00a034483050.","DOI":"10.1016\/j.hlc.2021.07.017"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Si S, Hillis SG, Sanfilippo FM, et al. Surgical aortic valve replacement in Australia, 2002\u20132015: temporal changes in clinical practice, patient profiles and outcomes. ANZ J Surg 2019;89:1061\u20137. https:\/\/doi.org\/10.1111\/ans.15370; PMID:\u00a031414527","DOI":"10.1111\/ans.15370"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"MacCarthy P, Smith D, Muir D, et al. Extended statement by the British Cardiovascular Intervention Society President regarding transcatheter aortic valve implantation. Interv Cardiol 2021;16:e03. https:\/\/doi.org\/10.15420\/icr.2021.02; PMID:\u00a033897829.","DOI":"10.15420\/icr.2021.02"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Adams H, Roberts-Thomson R, Patterson T, et al. The low-risk TAVI trials for severe aortic stenosis: future implications for Australian and New Zealand heart teams. Heart Lung Circ 2020;29:657\u201361. https:\/\/doi.org\/10.1016\/j.hlc.2020.01.006; PMID:\u00a032115372.","DOI":"10.1016\/j.hlc.2020.01.006"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Russo MJ, McCabe JM, Thourani VH, et al. Case volume and outcomes after TAVR with balloon-expandable prostheses: insights from TVT registry. J Am Coll Cardiol 2019;73:427\u2013440. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.031; PMID:\u00a030704575.","DOI":"10.1016\/j.jacc.2018.11.031"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Aroney C. TAVI or not TAVI \u2013 in low risk patients? That is the question. Heart Lung Circ 2017;26:749\u201352. https:\/\/doi.org\/10.1016\/j.hlc.2017.02.002; PMID:\u00a028343947.","DOI":"10.1016\/j.hlc.2017.02.002"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc 2017;6:e005960. https:\/\/doi.org\/10.1161\/JAHA.117.005960; PMID:\u00a028655733.","DOI":"10.1161\/jaha.117.005960"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Reinthaler M, Aggarwal SK, De Palma R, et al. Predictors of clinical outcome in transfemoral TAVI: circumferential iliofemoral calcifications and manufacturer-derived recommendations. Anatol J Cardiol 2015;15:297\u2013305. https:\/\/doi.org\/10.5152\/akd.2014.5311; PMID:\u00a025413227.","DOI":"10.5152\/akd.2014.5311"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Meredith IT, Walton A, Walters DL, et al. Mid-term outcomes in patients following transcatheter aortic valve implantation in the CoreValve Australia and New Zealand Study. Heart Lung Circ 2015;24:281\u201390. https:\/\/doi.org\/10.1016\/j.hlc.2014.09.023; PMID:\u00a025456213.","DOI":"10.1016\/j.hlc.2014.09.023"},{"key":"ref20","unstructured":"Moat NW, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol 2011;58:2130\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.050; PMID:22019110."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sinhal A, Hooper T, Bennetts J, et al. Transcatheter aortic valve implantation in Australia: insights from the ACOR TAVI registry. Heart Lung Circ 2019;28(Suppl 4):433. https:\/\/doi.org\/10.1016\/j.hlc.2019.06.702.","DOI":"10.1016\/j.hlc.2019.06.702"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Quine EJ, Duffy SJ, Stehli J, et al. Comparison of early outcomes in patients at estimated low, intermediate and high risk undergoing transcatheter aortic valve implantation: a multicentre Australian experience. Heart Lung Circ 2020;29:1174\u20139. https:\/\/doi.org\/10.1016\/j.hlc.2019.12.001; PMID:\u00a031980394.","DOI":"10.1016\/j.hlc.2019.12.001"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Yong G, Walton T, Ng M. et al. Performance and safety of transfemoral TAVI with SAPIEN XT in Australian patients with severe aortic stenosis at intermediate surgical risk: SOLACE-AU\u00a0Trial. Heart Lung Circ 2020;29:1839\u201346. https:\/\/doi.org\/10.1016\/j.hlc.2020.04.010; PMID:\u00a032712017.","DOI":"10.1016\/j.hlc.2020.04.010"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Chacko Y, Poon KK, Keegan W, et al. Outcomes of the first 300 cases of transcatheter aortic valve implantation at a high-volume Australian private hospital. Heart Lung Circ 2020;29:1534\u201341. https:\/\/doi.org\/10.1016\/j.hlc.2020.03.010; PMID:\u00a032305328.","DOI":"10.1016\/j.hlc.2020.03.010"},{"key":"ref25","unstructured":"Australian Institute of Health and Welfare. Heart, stroke and vascular disease \u2013 Australian facts. https:\/\/www.aihw.gov.au\/reports\/heart-stroke-vascular-disease\/cardiovascular-health-compendium\/data (accessed 11 January 2022)."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Allenby A, Kinsman L, Tham R, et al. The quality of cardiovascular disease prevention in rural primary care. Aust J Rural Health 2016;24:92\u20138. https:\/\/doi.org\/10.1111\/ajr.12224; PMID:\u00a026255899.","DOI":"10.1111\/ajr.12224"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Tuttle CS, Carrington MJ, Stewart S, Brown A. Overcoming the tyranny of distance: an analysis of outreach visits to optimise secondary prevention of cardiovascular disease in high-risk individuals living in Central Australia. Aust J Rural Health 2016;24:99\u2013105. https:\/\/doi.org\/10.1111\/ajr.12222; PMID:\u00a027087389.","DOI":"10.1111\/ajr.12222"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Paleri S, Tham JL, Jin D, et al. Transcatheter aortic valve implantation for severe aortic stenosis in the Australian regional population. Aust J Rural Health 2019;27:229\u201336. https:\/\/doi.org\/10.1111\/ajr.12508; PMID:\u00a031074928.","DOI":"10.1111\/ajr.12508"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kirk F, Eng L, Yadav S. Decentralisation of transcatheter aortic valve implantation \u2013 a review of outcomes and experiences in developing a service in remote Australia. Authorea 22 June 2021. https:\/\/doi.org\/10.22541\/au.162436851.15778725\/v1; preprint.","DOI":"10.22541\/au.162436851.15778725\/v1"}],"container-title":["Interventional Cardiology: Reviews, Research, Resources"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2021.27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T13:26:52Z","timestamp":1647869212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2021.27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.15420\/icr.2021.27","relation":{},"ISSN":["1756-1485","1756-1477"],"issn-type":[{"value":"1756-1485","type":"electronic"},{"value":"1756-1477","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"article-number":"e03"}}